8-KRegulation FD

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Dec 22, 2017)

Filed December 22, 2017For Securities:UNH

Summary

UnitedHealth Group (UNH) announced a significant international expansion move through a definitive purchase agreement and upcoming tender offer to acquire Empresas Banmédica, a leading healthcare provider and insurer in Chile, Colombia, and Peru. This strategic acquisition, valued at approximately $2.8 billion (CLP$1.7 trillion), represents a substantial investment in Latin American healthcare markets. The transaction is structured with UnitedHealth Group's wholly owned subsidiary launching a tender offer for 100% of Empresas Banmédica's outstanding shares. The two controlling shareholders, holding about 57% of the company, have committed to tendering their shares, providing strong initial support for the deal. The acquisition is anticipated to close in the first quarter of 2018, subject to standard closing conditions, indicating a swift integration timeline. This move underscores UnitedHealth Group's commitment to global growth and diversification within the healthcare sector.

Key Highlights

  • 1UnitedHealth Group to acquire Empresas Banmédica, a major healthcare provider in Chile, Colombia, and Peru.
  • 2Transaction valued at approximately $2.8 billion (CLP$1.7 trillion).
  • 3Deal involves a tender offer by a wholly owned UNH subsidiary for 100% of Banmédica's shares.
  • 4Controlling shareholders, representing 57% ownership, have agreed to tender their shares.
  • 5Expected closing in the first quarter of 2018, subject to customary conditions.
  • 6Tender offer period is scheduled from approximately December 27, 2017, to January 25, 2018.
  • 7Acquisition marks a significant expansion into Latin American healthcare markets.

Frequently Asked Questions

This 8-K filing announces UnitedHealth Group's definitive agreement to acquire Empresas Banmédica, a healthcare company operating in Chile, Colombia, and Peru. It details the terms of the acquisition, including the offer price and the expected timeline.

The total equity value of the transaction is approximately CLP$1.7 trillion, which translates to roughly USD$2.8 billion, based on the offer price of CLP$2150 per share.

The key parties are UnitedHealth Group (UNH), acting through a wholly owned subsidiary, and Empresas Banmédica. The two controlling shareholders of Empresas Banmédica are also significant parties as they have agreed to tender their shares.

The transaction is expected to close in the first quarter of 2018, subject to the satisfaction of customary terms and conditions.

This acquisition represents a major step in UnitedHealth Group's international expansion strategy, allowing it to significantly increase its presence and operations within the healthcare markets of Chile, Colombia, and Peru.